Categories: Stock Market News

Israel shares decrease at shut of commerce; TA 35 down 0.24%


Investing.com – Israel shares had been decrease after the shut on Sunday, as losses within the Biomed, Banking and Oil & Fuel sectors led shares decrease.

On the shut in Tel Aviv, the TA 35 declined 0.24%.

The most effective performers of the session on the TA 35 had been Teva Pharmaceutical Industries Ltd (TASE:TEVA), which rose 2.47% or 203.00 factors to commerce at 8,425.00 on the shut. In the meantime, Azrieli Group Ltd (TASE:AZRG) added 1.45% or 430.00 factors to finish at 30,170.00 and Massive Buying Facilities Ltd (TASE:BIG) was up 1.10% or 590.00 factors to 54,210.00 in late commerce.

The worst performers of the session had been Camtek Ltd (TASE:CAMT), which fell 2.41% or 740.00 factors to commerce at 29,980.00 on the shut. Ormat Applied sciences (TASE:ORA) declined 1.91% or 490.00 factors to finish at 25,100.00 and ICL Israel Chemical compounds Ltd (TASE:ICL) was down 1.57% or 28.00 factors to 1,752.00.

Falling shares outnumbered advancing ones on the Tel Aviv Inventory Trade by 285 to 177 and 75 ended unchanged.

Shares in Teva Pharmaceutical Industries Ltd (TASE:TEVA) rose to 5-year highs; gaining 2.47% or 203.00 to eight,425.00. Shares in Azrieli Group Ltd (TASE:AZRG) rose to 52-week highs; gaining 1.45% or 430.00 to 30,170.00. Shares in Massive Buying Facilities Ltd (TASE:BIG) rose to all time highs; rising 1.10% or 590.00 to 54,210.00.

Crude oil for February supply was up 0.92% or 0.64 to $70.26 a barrel. Elsewhere in commodities buying and selling, Brent oil for supply in March unchanged 0.00% or 0.00 to hit $73.79 a barrel, whereas the February Gold Futures contract fell 0.66% or 17.40 to commerce at $2,636.50 a troy ounce.

USD/ILS was up 0.55% to three.67, whereas EUR/ILS rose 0.52% to three.83.

The US Greenback Index Futures was down 0.09% at 107.79.

admin

Share
Published by
admin

Recent Posts

Sight sciences CFO Alison Bauerlein sells shares price $35,579

Sight Sciences , Inc. (NASDAQ:SGHT), a medical system firm with a market capitalization of $173…

9 minutes ago

Celldex Therapeutics’ SWOT evaluation: barzolvolimab potential drives inventory outlook

Celldex Therapeutics , Inc. (NASDAQ:CLDX), with a market capitalization of $1.84 billion, is a biopharmaceutical…

24 minutes ago

UAE agrees to roll over fee of $2 billion due by Pakistan

By Gibran Naiyyar Peshimam ISLAMABAD (Reuters) - The United Arab Emirates has agreed to roll…

24 minutes ago

US oil imports from Canada hit file forward of tariffs menace, EIA knowledge exhibits

NEW YORK (Reuters) - U.S. crude oil imports from Canada rose final week to the…

29 minutes ago

AI startup Anthropic to boost $2 billion at $60 billion valuation, sources say

By Anna Tong, Krystal Hu and Akash Sriram (Reuters) -AI startup Anthropic is close to…

39 minutes ago

Sterling and UK gilt costs tumble, pushing 10-year yield to highest since 2008

By David Milliken and Harry Robertson LONDON (Reuters) -British authorities bond costs fell sharply for…

44 minutes ago